Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA

Completed

Conditions studied: Lung Cancer

In brief

The primary objective of this study is to substantiate prediction accuracy(with a tighter 95% confidence interval compared to current diagnostic modalities), of a lung cancer biomarker for risk stratification of patients into high and low risk categories to aid in clinical evaluation of the patient.

Key facts

Study ID
NCT01309087
Run by
Allegro Diagnostics, Corp.
People needed
756
Starts
2009-01-01
Expected to finish
2013-05-01
Last updated by the study team
2014-03-26

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.